anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antikörper

LGALS9 was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. Zusätzlich bieten wir Ihnen Lectin, Galactoside-Binding, Soluble, 9 Kits (58) und Lectin, Galactoside-Binding, Soluble, 9 Proteine (34) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
LGALS9 16859 O08573
LGALS9 3965 O00182
LGALS9 25476 P97840
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Lectin, Galactoside-Binding, Soluble, 9 Antikörper auf antikoerper-online.de

Showing 10 out of 206 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-LGALS9 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Human Muscle 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Ratte Kaninchen Unkonjugiert WB Observed bind size: 36KD 100 μg Anmelden zum Anzeigen 4 bis 6 Tage
$240.00
Details
Human Kaninchen Unkonjugiert EIA, WB Western blot analysis of Galectin-9 Antibody (N-term) in WiDr cell line lysates (35ug/lane). 0.4 mL Anmelden zum Anzeigen 6 bis 8 Tage
$390.50
Details
Human Maus Unkonjugiert FACS 0.1 mg Anmelden zum Anzeigen 6 bis 8 Tage
$401.50
Details
Maus Ziege Unkonjugiert CyTOF, FACS, ICC, WB Detection of Galectin-9 in Mouse Thymocytes by Flow Cytometry. Galectin-9 in Mouse Splenocytes. Galectin-9 was detected in immersion fixed mouse splenocytes using Goat Anti-Mouse Galectin-9 Antigen Affinity-purified Polyclonal Antibody. Specific staining was localized to cytoplasm. 100 μg Anmelden zum Anzeigen 8 bis 9 Tage
$372.75
Details
Human Kaninchen Unkonjugiert IF, ELISA, WB Western blot analysis of extracts from HepG2 cells, using LEG9 Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of NIH-3T3 cells, using LEG9 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
$302.50
Details
Human Maus Unkonjugiert ELISA (Capture), FACS 0.1 mg Anmelden zum Anzeigen 6 bis 8 Tage
$401.50
Details
Rind (Kuh) Kaninchen Unkonjugiert WB Host: Rabbit Target Name: LGALS9 Sample Tissue: Human HCT15 Whole Cell Antibody Dilution: 1ug/ml 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Hund Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 7 bis 9 Tage
$551.83
Details
Human Kaninchen Unkonjugiert EIA, IF, IHC (p), IP, WB Immunofluorescence analysis of NIH-3T3 cells, using LEG9 Antibody. The picture on the right is treated with the synthesized peptide. Human Thymus: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μL Anmelden zum Anzeigen 11 bis 13 Tage
$542.85
Details

LGALS9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
,
,
, , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

Am meisten referenzierte anti-Lectin, Galactoside-Binding, Soluble, 9 Antikörper

  1. Human Polyclonal LGALS9 Primary Antibody für ELISA, WB - ABIN561667 : Bellac, Coimbra, Simon, Imboden, Leib: Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. in Neurobiology of disease 2007 (PubMed)
    Show all 2 Pubmed References

  2. Mouse (Murine) Polyclonal LGALS9 Primary Antibody für CyTOF, FACS - ABIN4899254 : Iqbal, Sampaio, Maione, Greco, Niki, Hirashima, Perretti, Cooper: Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. in The American journal of pathology 2011 (PubMed)

Weitere Antikörper gegen Lectin, Galactoside-Binding, Soluble, 9 Interaktionspartner

Mouse (Murine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. in a model of experimental autoimmune encephalomyelitis, we show that an agonist of DR3 (zeige TNFRSF25 Antikörper) suppressed disease, correlating with expansion of CD4 (zeige CD4 Antikörper)+Foxp3 (zeige FOXP3 Antikörper)+ Tregs, and this protective effect was lost in Galectin-9-/- mice

  2. Galectin 9 is a novel dectin 1 (zeige CLEC7A Antikörper) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (zeige CLEC7A Antikörper)-galectin 9 axis, CD4 (zeige CD4 Antikörper)(+) and CD8 (zeige CD8A Antikörper)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  3. The Gal-9/Tim-3 (zeige HAVCR2 Antikörper) signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.

  4. These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.

  5. galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.

  6. Gal-9 has a role in the maintenance of hepatic homeostasis and preventing liver ischemia-reperfusion injury

  7. Gal-9, a natural TIM-3 (zeige HAVCR2 Antikörper) ligand, was produced primarily by and released from ischemia-reperfusion-stressed hepatocytes, both in vivo and in vitro.

  8. Galectin-9 functions as an astrocyte-microglia communication signal and promotes cytokine production from microglia in a Tim-3 (zeige HAVCR2 Antikörper) independent manner.

  9. galectin-9, in addition to being an effector molecule for regulatory T cells cells, acts synergistically with TGF-beta (zeige TGFB1 Antikörper) to enforce iTreg cell differentiation and maintenance.

  10. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.

Human Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. Tim3 (zeige HAVCR2 Antikörper)/Gal-9 alleviates the inflammation of TAO patients via suppressing Akt (zeige AKT1 Antikörper)/NF-kappaB (zeige NFKB1 Antikörper) signaling pathway.

  2. Low Gal-9 expression is associated with pancreatic and ampullary cancer.

  3. Galectin 9 is a novel dectin 1 (zeige CLEC7A Antikörper) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (zeige CLEC7A Antikörper)-galectin 9 axis, CD4 (zeige CD4 Antikörper)(+) and CD8 (zeige CD8A Antikörper)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  4. X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site has been presented.

  5. These findings may indicate that an increase in the Gal-9 level, a novel immune checkpoint molecule, can reflect immune-related adverse effects of various biotherapies.

  6. Our data suggest a role of galectin-9 in regulating HIV transcription and viral production in vivo during therapy

  7. these data suggest that the high Tim-3 (zeige HAVCR2 Antikörper) expression in monocytes could be utilized by tumor-promoting Gal-9 expression on CD4 (zeige CD4 Antikörper)(+) T cells

  8. this study shows that in osteosarcoma patients, Tim3 (zeige HAVCR2 Antikörper) expression did not directly mediate immune suppression, but the interaction between Tim3 (zeige HAVCR2 Antikörper)+ T cells and monocytes, naive CD4 (zeige CD4 Antikörper)+ T cells, and Gal9-expressing CD4 (zeige CD4 Antikörper)+ CD25 (zeige IL2RA Antikörper)+ Tregs could resulting in progressive suppression of Th1 (zeige TH1L Antikörper) responses

  9. The human recombinant galectin-9 has demonstrated anti-cancer activities, including inducing apoptosis in hematological, dermatological and gastrointestinal malignancies. In this review, the molecular characteristics, history and apoptosis-inducing potential of galectin-9 are described. [review]

  10. Results showed that in acute febrile phase, galectin-9 and galectin-3BP were induced in dengue patients compared to healthy controls suggesting that both molecules might be important inflammatory mediators in acute dengue virus infection.

Cow (Bovine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. The Tim-3 (zeige HAVCR2 Antikörper)/Gal-9 pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.

  2. The relative abundance of PIBF (zeige PIBF1 Antikörper), LGALS1 (zeige LGALS1 Antikörper), LGALS3 (zeige LGALS2 Antikörper), LGALS3BP (zeige LGALS3BP Antikörper), and LGALS9 mRNA would display a differential expression pattern in the endometrium.

Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antigen-Profil

Protein Überblick

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene.

Genbezeichner und Symbole assoziert mit LGALS9

  • galectin 9 L homeolog (lgals9.L) Antikörper
  • galectin 9 (lgals9) Antikörper
  • lectin, galactoside-binding, soluble, 9 (galectin 9)-like 3 (lgals9l3) Antikörper
  • galectin 9 (LGALS9) Antikörper
  • galectin 9 (Lgals9) Antikörper
  • lectin, galactose binding, soluble 9 (Lgals9) Antikörper
  • AA407335 Antikörper
  • AI194909 Antikörper
  • AI265545 Antikörper
  • ecalectin Antikörper
  • gal-9 Antikörper
  • galectin-9 Antikörper
  • HUAT Antikörper
  • Lgals5 Antikörper
  • LGALS9 Antikörper
  • LGALS9A Antikörper
  • LGALS35 Antikörper
  • UAT Antikörper
  • UATP.I Antikörper
  • wu:fd20c09 Antikörper
  • zgc:111833 Antikörper

Bezeichner auf Proteinebene für LGALS9

lectin, galactoside-binding, soluble, 9 , galactoside-binding soluble lectin 9 , galectin 9 , lectin, galactoside-binding, soluble, 9 (galectin 9) , galectin-9 , lectin, galactose binding, soluble 5 , ecalectin , gal-9 , tumor antigen HOM-HD-21 , urate transporter/channel protein , 36 kDa beta-galactoside-binding lectin , Lectin galactose binding soluble 9 (Galectin-9) , Lectin, galactose binding, soluble 9 (Galectin-9) , UAT , urate transporter/channel , urate transporter , urate transporter/channel protein, isoform (UATp,i)

GENE ID SPEZIES
733366 Xenopus laevis
100145704 Xenopus (Silurana) tropicalis
327284 Danio rerio
454519 Pan troglodytes
100350347 Oryctolagus cuniculus
100728329 Cavia porcellus
16859 Mus musculus
3965 Homo sapiens
25476 Rattus norvegicus
442861 Canis lupus familiaris
396972 Sus scrofa
510813 Bos taurus
Ausgewählte Anbieter für anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antikörper
Haben Sie etwas anderes gesucht?